A Heavy Price: The Economic and Social Costs of GLP-1 Weight Loss Drugs
Online Journal | Justin Plank | January 2025 Background Every year, the United States spends an estimated $173 billion treating obesity-related diseases like diabetes and heart disease, more than the annual budgets of 42 U.S. states combined. Yet, medications like Wegovy and Ozempic, which could help address these issues, remain priced at over $1,300 per …